Between 2024 and 2028, Alzheimer's disease mortality in Canada is forecasted to decrease from 13.6 to 11.9 deaths per hundred thousand persons. In 2023, the rate stood at a slightly higher level than 2024, indicating a continuous declining trend. Year-on-year decreases are anticipated, with mortality rates showing a consistent downward trajectory. The compound annual growth rate (CAGR) over the five-year forecast period anticipates an average decrease, signaling improvements in healthcare practices or interventions.
Future trends to watch for include advancements in Alzheimer's treatment and preventive measures, demographic changes, and healthcare policy impacts that could further affect mortality rates. Emerging technologies and new research developments might also significantly contribute to these trends.
